Compare Ganirelix (evidence A) and Kisspeptin (evidence C) on mechanism, clinical status, safety, and dosing.
Ganirelix is a synthetic GnRH antagonist decapeptide (MW ~1570.4 g/mol) FDA-approved for the prevention of premature LH surges during controlled ovarian…
Kisspeptin is an endogenous neuropeptide encoded by the KISS1 gene that plays a critical role in regulating reproductive hormone secretion. It binds GPR54…
Full profiles: Ganirelix, Kisspeptin.